11-114679689-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_182495.6(NXPE2):c.59G>A(p.Arg20Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000187 in 1,549,676 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_182495.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NXPE2 | NM_182495.6 | c.59G>A | p.Arg20Gln | missense_variant | 2/6 | ENST00000389586.6 | NP_872301.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NXPE2 | ENST00000389586.6 | c.59G>A | p.Arg20Gln | missense_variant | 2/6 | 5 | NM_182495.6 | ENSP00000374237.4 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152014Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000573 AC: 9AN: 157086Hom.: 0 AF XY: 0.0000843 AC XY: 7AN XY: 83044
GnomAD4 exome AF: 0.0000172 AC: 24AN: 1397662Hom.: 0 Cov.: 29 AF XY: 0.0000232 AC XY: 16AN XY: 689444
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152014Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74224
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 09, 2024 | The c.59G>A (p.R20Q) alteration is located in exon 2 (coding exon 2) of the NXPE2 gene. This alteration results from a G to A substitution at nucleotide position 59, causing the arginine (R) at amino acid position 20 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at